Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
Abstract Background Glioma, particularly glioblastoma (GBM), is a highly aggressive tumor with limited responsiveness to immunotherapy. PANoptosis, a form of programmed cell death merging pyroptosis, apoptosis, and necroptosis, plays an important role in reshaping the tumor microenvironment (TME) an...
Saved in:
Main Authors: | Yonghua Cai, Heng Xiao, Shuaishuai Xue, Peng Li, Zhengming Zhan, Jie Lin, Zibin Song, Jun Liu, Wei Xu, Qixiong Zhou, Songtao Qi, Xi’an Zhang, Ziyi Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-025-03301-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring PANoptosis in head and neck cancer: A novel approach to cancer therapy
by: Li Wang, et al.
Published: (2025-01-01) -
RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
by: Wei Wei, et al.
Published: (2025-01-01) -
SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis
by: Fanghui Chen, et al.
Published: (2025-01-01) -
Identification and Functional Analysis of PANoptosis‐Associated Genes in the Progression From Sepsis to ARDS
by: Zhong‐Hua Lu, et al.
Published: (2025-01-01) -
Advancements in targeted and immunotherapy strategies for glioma: toward precision treatment
by: Guangyuan Gong, et al.
Published: (2025-01-01)